Technical Analysis for PTCT - PTC Therapeutics, Inc.

Grade Last Price % Change Price Change
grade B 39.47 0.20% 0.08
PTCT closed up 0.2 percent on Friday, May 24, 2019, on 55 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Flat
See historical PTCT trend table...

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
Multiple of Ten Bearish Other 0.00%
Multiple of Ten Bearish Other 0.20%
Multiple of Ten Bullish Other -2.28%
200 DMA Support Bullish -1.47%
Crossed Above 20 DMA Bullish -1.47%
Crossed Above 50 DMA Bullish -1.47%
MACD Bullish Signal Line Cross Bullish -1.47%
180 Bullish Setup Bullish Swing Setup -1.47%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -1.47%

Older signals for PTCT ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
PTC Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of orally administered and proprietary small-molecule drugs for patients living with serious and life-threatening conditions, including genetic and neuromuscular disorders, cancer, and infectious diseases. Its approach includes post-transcriptional control, RNA biology, and gene expression modulation by small-molecules. The company has strategic alliances with AstraZeneca; Celgene Corporation; Cystic Fibrosis Foundation; Genzyme Corporation; Gilead; Muscular Dystrophy Association; Merck & Co., Inc.; Parent Project Muscular Dystrophy; Pfizer Inc.; Roche; Spinal Muscular Atrophy Foundation; and Wellcome Trust. PTC Therapeutics, Inc. was founded in 1998 and is based in South Plainfield, New Jersey.
Biotechnology Biopharmaceutical Cancer Life Sciences Infectious Diseases New Jersey Gene Expression Neurological Disorders Astrazeneca Celgene Muscular Dystrophy Spinal Muscular Atrophy Dystrophy Neurodegenerative Disorders Neuromuscular Disorders
Is PTCT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 52.95
52 Week Low 27.53
Average Volume 760,490
200-Day Moving Average 37.2275
50-Day Moving Average 38.0006
20-Day Moving Average 38.715
10-Day Moving Average 39.541
Average True Range 1.8609
ADX 21.96
+DI 28.7192
-DI 20.2459
Chandelier Exit (Long, 3 ATRs ) 36.4173
Chandelier Exit (Short, 3 ATRs ) 40.8127
Upper Bollinger Band 41.7908
Lower Bollinger Band 35.6392
Percent B (%b) 0.62
BandWidth 15.889449
MACD Line 0.6158
MACD Signal Line 0.6256
MACD Histogram -0.0098
Fundamentals Value
Market Cap 1.63 Billion
Num Shares 41.4 Million
EPS -3.05
Price-to-Earnings (P/E) Ratio -12.94
Price-to-Sales 5.48
Price-to-Book 3.95
PEG Ratio 0.73
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 41.89
Resistance 3 (R3) 42.00 41.32 41.48
Resistance 2 (R2) 41.32 40.70 41.26 41.35
Resistance 1 (R1) 40.39 40.32 40.05 40.28 41.21
Pivot Point 39.71 39.71 39.54 39.65 39.71
Support 1 (S1) 38.78 39.09 38.44 38.67 37.73
Support 2 (S2) 38.10 38.71 38.04 37.59
Support 3 (S3) 37.17 38.10 37.46
Support 4 (S4) 37.06